Lecanemab in the treatment of early Alzheimer's disease: An observational study based on 7.0T ultra‐high field MRI

Abstract

Background: Previous research has demonstrated the effectiveness of lecanemab in treating early Alzheimer's disease (AD). However, its validation in the Hunan region of China remains limited. Traditional evaluation methods lack precision, particularly in brain imaging technologies. To address this gap, this study utilizes 7.

The paper